Literature DB >> 3497099

Deficiency of interleukin 2 inhibitor activity in serum from autoimmune-prone mice.

K Kobayashi, T Kasama, T Fukushima, K Kasahara, M Tabata, F Sekine, M Negishi, H Ide, T Takahashi.   

Abstract

To study the mechanisms that regulate the activity of interleukin 2 (IL 2) and possibly limit its activity, we have examined normal mouse serum for their ability to inhibit IL 2-mediated proliferation of a cloned IL 2-dependent cytotoxic T lymphocyte line (CTLL). Normal mouse serum contains a factor capable of inhibiting IL 2 dependent proliferation of CTLL cells. This factor is absorbed with IL 2-dependent cells, but not with IL 2 molecules. Decreased activity of the inhibitor is observed in serum from autoimmune-prone mice such as NZB and NZBWF 1 hybrid mice. The results suggest that the serum IL 2 inhibitor may play an important role in the in vivo regulatory mechanism of IL 2 activity and that lack of the inhibitor may be associated with aberrant immune functions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497099     DOI: 10.3109/08820138709055711

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  1 in total

1.  Immunotherapy of collagen-induced arthritis by a T-cell antiproliferative molecule.

Authors:  D J Spannaus-Martin; R Holmdahl; T F Kresina
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.